Imperative Care
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Imperative Care sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Imperative Care: 4 sponsored US clinical trials, 2 recruiting.
Imperative Care sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Arterial Thromboembolism, with 1 trials.
Upper-quartile sponsor footprint
Imperative Care sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Continuous Dual Aspiration Technique With Zoom System for Stroke
NCT07491952
Aspiration Thrombectomy Using the Symphony or Prodigy System
NCT07350499
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
NCT06062329
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
NCT04129125
Therapeutic Areas
What is open in the Imperative Care pipeline
2 recruiting of 4 indexed (50% open); 2 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Arterial Thromboembolism (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Imperative Care: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Imperative Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this Imperative Care page
4 registered trials is a research-attention snapshot, not an endorsement of Imperative Care or any single study.
- 2 of Imperative Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Arterial Thromboembolism is the condition Imperative Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Arterial Thromboembolism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Imperative Care pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.